Biosensors (Nov 2024)

Commercial Wearables for the Management of People with Autism Spectrum Disorder: A Review

  • Jonathan Hernández-Capistrán,
  • Giner Alor-Hernández,
  • Humberto Marín-Vega,
  • Maritza Bustos-López,
  • Laura Nely Sanchez-Morales,
  • Jose Luis Sanchez-Cervantes

DOI
https://doi.org/10.3390/bios14110556
Journal volume & issue
Vol. 14, no. 11
p. 556

Abstract

Read online

Autism Spectrum Disorder (ASD) necessitates comprehensive management, addressing complex challenges in social communication, behavioral regulation, and sensory processing, for which wearable technologies offer valuable tools to monitor and support interventions. Therefore, this review explores recent advancements in wearable technology, categorizing devices based on executive function, psychomotor skills, and the behavioral/emotional/sensory domain, highlighting their potential to improve ongoing management and intervention. To ensure rigor and comprehensiveness, the review employs a PRISMA-based methodology. Specifically, literature searches were conducted across diverse databases, focusing on studies published between 2014 and 2024, to identify the most commonly used wearables in ASD research. Notably, 55.45% of the 110 devices analyzed had an undefined FDA status, 23.6% received 510(k) clearance, and only a small percentage were classified as FDA Breakthrough Devices or in the submission process. Additionally, approximately 50% of the devices utilized sensors like ECG, EEG, PPG, and EMG, highlighting their widespread use in real-time physiological monitoring. Our work comprehensively analyzes a wide array of wearable technologies, including emerging and advanced. While these technologies have the potential to transform ASD management through real-time data collection and personalized interventions, improved clinical validation and user-centered design are essential for maximizing their effectiveness and user acceptance.

Keywords